Business Express is an online portal that covers the latest developments in the world of business and finance. From startups and entrepreneurship to mergers and acquisitions, Business Express provides reporting on the stories that matter most to business leaders and decision-makers.The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
2024 02 20T070336Z 1 LYNXNPEK1J065 RTROPTP 4 FRESENIUS CARE RESULTS scaled - Business Express

Dialysis firm FMC sees robust 2024 earnings growth after strong Q4

Dialysis firm FMC sees robust 2024 earnings growth after strong Q4

GDANSK (Reuters) – Fresenius Medical Care on Tuesday forecast its core earnings to grow by a mid- to high-teens percentage this year, after the German dialysis specialist’s fourth-quarter earnings topped market expectations.

Last year, the company’s adjusted operating income increased by 15% to 1.7 billion euros ($1.83 billion).

“Based on the turnaround progress achieved last year, we have a strong foundation to build on to make 2024 a year of accelerated profitable growth,” CEO Helen Giza said.

Supported by its cost-cutting plan FME25, the German firm managed to save about 350 million euros during the year, almost 50 million euros more than initially planned.

In 2023, FMC sold 127 facilities with a headcount of more than 4,500 employees in the United States, Argentina and Australia.

FMC, which employs 120,000 people in 4,000 clinics globally, said its adjusted operating income grew 18% to 555 million euros in the October-December period, compared with a median consensus of 546 million in a poll by Vara Research.

Earnings for FMC, the world’s biggest dialysis provider, are recovering after they were hit by slower patient flows due to excess mortality rates during the pandemic.

Its turnaround plan and a 175-million-euro one-off payment related to a legal settlement in the United States also helped lift its quarterly numbers.

Don't miss out on any breaking news or insightful opinions!
Subscribe to our free newsletter and stay updated on the go!

By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.

The company used the proceeds to reduce its net debt by 11% to 10.8 billion euros.

FMC proposed a dividend of 1.19 euros per share for 2023, representing a 6% annual increase.

Shares rose 1.3% in the Lang & Schwarz pre-market indications.

($1 = 0.9285 euros)


(Reporting by Andrey Sychev and Chiara Holzhaeuser in Gdansk; Editing by Milla Nissi and Sherry Jacob-Phillips)


Recent Post: